Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Br J Haematol. 2015 Oct 22;172(3):392–400. doi: 10.1111/bjh.13834

Table V.

Multivariate analysis of covariates for time to disease relapse

Parameter Hazard ratio
(95% confidence interval)
P value
At Complete Remission (N=260)

Age 1.006 (0.992, 1.021) 0.39
WBC 1.005 (1.003, 1.006) <0.0001
Cytogenetics 0.815 (0.498, 1.333) 0.41
MRD at CR 2.263 (1.432, 3.576) 0.0005

At 3 Months from Therapy Initiation (N=216)

Age 1.003 (0.989, 1.018) 0.67
WBC 1.004 (1.003, 1.006) <0.0001
Cytogenetics 0.925 (0.570, 1.503) 0.75
MRD at 3 Months 1.976 (0.790, 4.944) 0.145

At 6 Months from Therapy Initiation (N=166)

Age 1.001 (0.987, 1.016) 0.86
WBC 1.004 (1.002, 1.006) <0.0001
Cytogenetics 1.059 (0.653, 1.715) 0.82
MRD at 6 Months 3.969 (1.214, 12.691) 0.02

WBC, white blood cell count; MRD, minimal residual disease; CR, complete remission